Try Artisan’s All-in-one Outbound Sales Platform & AI BDR
Ava automates your entire outbound demand generation so you can get leads delivered to your inbox on autopilot. She operates within the Artisan platform, which consolidates every tool you need for outbound:
300M+ High-Quality B2B Prospects, including E-Commerce and Local Business Leads
Automated Lead Enrichment With 10+ Data Sources
Full Email Deliverability Management
Multi-Channel Outreach Across Email & LinkedIn
Human-Level Personalization
Daily deep dives
📺 Fairground Entertainment is pioneering AI-generated television with $4 million in seed funding and plans to launch its first wave of programming in Q3 2025. Founded by Xumo's Colin Petrie-Norris, the studio has over a dozen shows in production that reimagine public domain properties like Dracula using various generative AI platforms. The Laguna Beach-based startup is targeting genres including animation, children's content, horror, and science fiction while emphasizing that content quality, not just technological novelty, will determine its success. This venture signals growing confidence in AI's ability to create commercially viable entertainment, potentially reshaping how television content is produced.
🛡️ Trajectory Labs, a nonprofit AI safety hub has launched in Toronto with funding from Open Philanthropy to accelerate local AI safety initiatives. Operational since January 2025, the organization offers workspace for 30 practitioners and hosts regular events from casual meetups to formal presentations. The initiative fosters a peer network for mentorship and collaboration while providing free membership to qualified applicants. This model demonstrates how localized, physical infrastructure can enhance regional contributions to AI safety research.
🧠 Notion has launched an enterprise AI toolkit that integrates multiple large language models including OpenAI's GPT-4.1 and Anthropic's Claude 3.7 directly into its productivity platform. Users can switch between different AI models while accessing new features such as AI meeting notes, enterprise search, and a dedicated research mode. Already adopted by tech companies like OpenAI and Vercel, the platform combines third-party models with fine-tuned AI systems while connecting to various applications for enhanced enterprise functionality. This integration strategy directly challenges both specialized AI services and model providers by offering businesses a unified workspace with comprehensive AI capabilities.
📈 Taiwan's Foxconn is reporting record profits from the AI server boom, with Q1 2025 earnings expected to surge 72% year-over-year to $1.25 billion. As a key manufacturer for both Apple's iPhones and Nvidia's AI servers, the company has seen first-quarter revenue jump 24.2% despite its stock declining 14% year-to-date due to US-China trade tensions. Foxconn's diversification into electric vehicles through partnerships with Mitsubishi Motors highlights its strategic pivot beyond traditional electronics. The company's new manufacturing facility in Mexico for Nvidia AI servers now faces additional uncertainty with potential US tariffs, showcasing how geopolitics continues to complicate the AI hardware supply chain.
🤝 Le Monde's partnership with AI startup Perplexity signals a strategic shift in media-AI relations from confrontation to collaboration. The French newspaper gains access to Perplexity's technology for developing new AI products while the startup can incorporate Le Monde's content into its search responses. This mutually beneficial approach follows a growing industry trend, with over a dozen media organizations including the Los Angeles Times forming similar agreements. Rather than pursuing litigation over unauthorized content use, these partnerships create alternative revenue streams through advertising revenue sharing, potentially offering a sustainable model for media organizations navigating the AI landscape.
🧬 Absci's AI-designed antibody therapy for irritable bowel disease has entered Phase I clinical trials with 40 healthy adult participants, marking a significant milestone as one of the first AI-created drugs to reach human testing. The ABS-101 treatment targets the TL1A protein linked to inflammatory autoimmune diseases and is being administered subcutaneously, an unusual approach for initial trials. Using generative AI, Absci claims to have slashed development time from 5 years to just 24 months while reducing costs from the traditional $50-100 million to only $15 million. This breakthrough could signal a fundamental shift in pharmaceutical development if interim data, expected in the second half of 2025, proves promising.
🌐 The Trump administration is considering a deal to allow the UAE to import over a million advanced Nvidia AI chips through 2027, significantly relaxing export controls established under Biden. The proposed agreement would permit 500,000 chips annually, with 20% allocated to Abu Dhabi AI firm G42 and the rest to US companies operating in the UAE. This policy shift highlights tensions between preventing technology transfer to China and securing economic deals with Middle Eastern nations, coming shortly after Trump's $600 billion investment commitment from Saudi Arabia. Critics worry the UAE could potentially serve as a conduit for China to access US AI technology, while companies like OpenAI might benefit from expanded data center capacity in the region.